Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
10.90
+0.40 (3.81%)
At close: Jun 18, 2025, 4:00 PM
10.80
-0.10 (-0.92%)
After-hours: Jun 18, 2025, 7:55 PM EDT
Phathom Pharmaceuticals Employees
Phathom Pharmaceuticals had 427 employees as of December 31, 2024. The number of employees decreased by 25 or -5.53% compared to the previous year.
Employees
427
Change (1Y)
-25
Growth (1Y)
-5.53%
Revenue / Employee
$191,707
Profits / Employee
-$809,813
Market Cap
759.17M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
PHAT News
- 2 days ago - Phathom Pharmaceuticals Announces FDA Correction to Orange Book Listing, Confirming 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets Through May 3, 2032 - GlobeNewsWire
- 8 days ago - Tiny Phathom Pharmaceuticals Just An Got FDA Blessing And Big-Time Upside: Buy - Seeking Alpha
- 12 days ago - Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets through May 3, 2032 - GlobeNewsWire
- 4 weeks ago - Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Phathom Pharmaceuticals, Inc. (PHAT) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 7 weeks ago - Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2025 Annual Meeting - GlobeNewsWire